Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention

Published:2020-05 Issue:19 Volume:75 Page:2403-2413
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Angiolillo Dominick J.,Baber Usman,Sartori Samantha,Briguori Carlo,Dangas George,Cohen David J.,Mehta Shamir R.,Gibson C. Michael,Chandiramani Rishi,Huber Kurt,Kornowski Ran,Weisz Giora,Kunadian Vijay,Oldroyd Keith G.,Ya-Ling Han,Kaul Upendra,Witzenbichler Bernhard,Dudek Dariusz,Sardella Gennaro,Escaned Javier,Sharma Samin,Shlofmitz Richard A.,Collier Timothy,Pocock Stuart,Mehran Roxana

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. ACC/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison;Capodanno;J Am Coll Cardiol,2018

2. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

3. Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention;Genereux;J Am Coll Cardiol,2015

4. Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigms;Buccheri;Expert Opin Drug Saf,2019

5. Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention;Capodanno;Nat Rev Cardiol,2018

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet Therapy and Anticoagulation before, during, and after Acute Coronary Syndrome;Journal of Clinical Medicine;2024-04-17

2. Ticagrelor monotherapy after a short course of dual antiplatelet therapy with ticagrelor plus aspirin following percutaneous coronary intervention in patients with versus without diabetes mellitus: a meta-analysis of randomized trials;BMC Cardiovascular Disorders;2024-03-19

3. Duration of Dual Antiplatelet Treatment After Percutaneous Coronary Intervention in Patients With Diabetes: A Systematic Review and Meta-analysis;Journal of Cardiovascular Pharmacology;2024-01

4. Efficacy and Safety of Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stent in Patients With Diabetes Mellitus: A Systematic Review and Meta- analysis;Philippine Journal of Cardiology;2023-12-15

5. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024;Diabetes Care;2023-12-11